Development of activated endothelial targeted high-density lipoprotein nanoparticles is a research paper published in Frontiers in Pharmacology (2022). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R44 GM145103 HL134569 R21 TR003185 R35 GM131835 T32 GM 7767 T32 HL125242
American Heart Association
Grant: 19PRE34400017
University of Michigan
Grant: G024210
NCATS NIH HHS
Grant: R21 TR003185
NIGMS NIH HHS
Grant: T32 GM007767
NIGMS NIH HHS
Grant: R35 GM131835
NHLBI NIH HHS
Grant: T32 HL125242
National Institutes of Health
Grant: 1R01HL134569-01A1
KLF14 and Atherosclerosis
National Institutes of Health
Grant: 5T32GM007767-33
Interdepartmental Training in Pharmacological Sciences
National Institutes of Health
Grant: 5R44GM145103-02
Development of Synthetic High-Density Lipoproteins for Treatment of Sepsis
National Institutes of Health
Grant: 5T32HL125242-09
Training Program in Translational Cardiovascular Research and Entrepreneurship
National Institutes of Health
Grant: 3R35GM131835-04S1
12-HETrE regulation of blood coagulation, hemostasis, and thrombosis
National Institutes of Health
Grant: 1R21TR003185-01A1
Biomarkers for 12-lipoxygenase inhibition as a therapeutic intervention for heparin-induced thrombocytopenia and thrombosis (HIT/T)
FWCI
0.42
Citation Percentile
0.5%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals